US Patent 8568721 Method of treating rheumatoid arthritis with an anti-IL-6R antibody
Patent 8568721 was granted and assigned to Regeneron Pharmaceuticals, Inc. on October, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08568721 Method of treating rheumatoid arthritis with an anti-IL-6R antibody US Patent 8568721 Method of treating rheumatoid arthritis with an anti-IL-6R antibody
Infobox
Patent Number
08568721
Patent Number
8568721
Edits on 18 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08568721 Method of treating rheumatoid arthritis with an anti-IL-6R antibody
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08568721
Date of patent
October 29, 2013
Patent application number
13462938
Date Filed
May 3, 2012
Patent primary examiner
Find more entities like US Patent 8568721 Method of treating rheumatoid arthritis with an anti-IL-6R antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
